ROCK Inhibitors in Corneal Diseases and Glaucoma—A Comprehensive Review of These Emerging Drugs

ROCK Inhibitors in Corneal Diseases and Glaucoma—A Comprehensive Review of These Emerging Drugs

Rho kinase (ROCK) inhibitors have gained significant attention as emerging novel treatment options in the field of ophthalmology in recent years. The evidence supporting their efficacy in glaucoma and corneal pathology includes both in vitro and clinical studies. Among the available options, ripasud...

Full description

Bibliographic Details
Main Authors: Luca Pagano, Jason William Lee, Matteo Posarelli, Giuseppe Giannaccare, Stephen Kaye, Alfredo Borgia
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Journal of Clinical Medicine
Subjects:
rho kinase
cornea guttata
Descemet membrane
glaucoma
ripasudil
netarsudil
Online Access:https://www.mdpi.com/2077-0383/12/21/6736

Similar Items

Similar Items